Persistent Epithelial Defect clinical trials

Explore recruiting persistent epithelial defect clinical trials.

Recruiting persistent epithelial defect studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Persistent Epithelial Defect trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomized clinical trial to evaluate the efficacy of fibrin membrane graft with eye drops concentrated in autologous growth factors in primary pterygium surgery compared to amniotic membrane graft in terms of recurrence during the first year after surgery.

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

Multicenter, controlled, randomized, observer-blinded clinical trial to evaluate the efficacy and safety of insulin eye drops (1 IU/ml) in the treatment of persistent corneal epithelial defect.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Multi-Center, Randomized, Parallel, Double Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of Neurotrophic Keratopathy (SEER-2)

Italy, Poland, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

SEER-3: A Phase 3, Multi-Center, Randomized, Parallel, Double Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of Neurotrophic Keratopathy

Italy, Spain, Germany, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Persistent Epithelial Defect trials by city

Persistent Epithelial Defect in Toronto Persistent Epithelial Defect in Vancouver Persistent Epithelial Defect in Montreal Persistent Epithelial Defect in Calgary Persistent Epithelial Defect in Edmonton Persistent Epithelial Defect in Ottawa Persistent Epithelial Defect in Winnipeg Persistent Epithelial Defect in Quebec City Persistent Epithelial Defect in Hamilton Persistent Epithelial Defect in Kitchener Persistent Epithelial Defect in London Persistent Epithelial Defect in Halifax Persistent Epithelial Defect in New York Persistent Epithelial Defect in Los Angeles Persistent Epithelial Defect in Chicago Persistent Epithelial Defect in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease